NASDAQ:SNES - SenesTech Stock Price, Forecast & News

SenesTech trades on the NASDAQ under the ticker symbol "SNES."

SenesTech Inc (NASDAQ:SNES) posted its earnings results on Tuesday, November, 12th. The company reported ($0.09) earnings per share (EPS) for the quarter. The company had revenue of $0.04 million for the quarter, compared to analyst estimates of $0.04 million. SenesTech had a negative return on equity of 200.80% and a negative net margin of 4,568.52%. View SenesTech's Earnings History.

SenesTech is scheduled to release their next quarterly earnings announcement on Thursday, March 26th 2020. View Earnings Estimates for SenesTech.

Press coverage about SNES stock has trended somewhat positive recently, according to InfoTrie Sentiment. InfoTrie rates the sentiment of media coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. SenesTech earned a coverage optimism score of 2.0 on InfoTrie's scale. They also gave media coverage about the company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an effect on the stock's share price in the next several days. View News Stories for SenesTech.

Some companies that are related to SenesTech include Wynnstay Group (WYN), Arcadia Biosciences (RKDA), Evogene (EVGN), China Green Agriculture (CGA), Eden Research (EDEN), Bion Environmental Technologies (BNET), Kiwa Bio-Tech Products Group (KWBT) and Cavitation Technologies (CVAT).

Based on aggregate information from My MarketBeat watchlists, some companies that other SenesTech investors own include TransEnterix (TRXC), Carrizo Oil & Gas (CRZO), Marathon Oil (MRO), Auris Medical (EARS), Histogenics (HSGX), McDermott International (MDR), Melinta Therapeutics (MLNT), ZIOPHARM Oncology (ZIOP), Adamis Pharmaceuticals (ADMP) and Catabasis Pharmaceuticals (CATB).

(SNES) raised $15 million in an initial public offering on Thursday, December 8th 2016. The company issued 1,900,000 shares at a price of $8.00 per share. Roth Capital Partners served as the underwriter for the IPO and Craig-Hallum Capital Group was co-manager.

SenesTech's stock is owned by many different of institutional and retail investors. Top institutional investors include Sabby Management LLC (0.17%). Company insiders that own SenesTech stock include Cheryl Ann Dyer, Julia Ann Williams, Kenneth S Siegel and Loretta Powers Mayer. View Institutional Ownership Trends for SenesTech.

SNES stock was purchased by a variety of institutional investors in the last quarter, including Sabby Management LLC. Company insiders that have bought SenesTech stock in the last two years include Julia Ann Williams and Kenneth S Siegel. View Insider Buying and Selling for SenesTech.

Shares of SNES can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of SNES stock can currently be purchased for approximately $0.57.

SenesTech has a market capitalization of $16.12 million and generates $300,000.00 in revenue each year. The company earns $-11,910,000.00 in net income (profit) each year or ($0.63) on an earnings per share basis. SenesTech employs 40 workers across the globe.View Additional Information About SenesTech.

The official website for SenesTech is http://www.senestech.com/.

SenesTech's mailing address is 3140 NORTH CADEN COURT SUITE 1, FLAGSTAFF AZ, 86004. The company can be reached via phone at 928-779-4143 or via email at [email protected]